1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends

Analysis of the Global Diabetes Drug Delivery Market : Future Options for End Users

  • March 2015
  • 77 pages
  • Frost & Sullivan
Report ID: 2795969

Summary

Table of Contents

Methodology

The analysis in this research service is based on the following:
•Information collected through discussions with market participants
•Information from secondary pharmaceutical companies, medical device companies involved in drug delivery systems, related Web sites, and other credible sources
•Public announcements from key market leaders, suppliers, new market entrants, and other companies
•Frost & Sullivan’s published research and market and technology expertise All market figures and shares listed within this report are Frost & Sullivan's assessments based on the research conducted. For Market Engineering research, Frost & Sullivan utilises tried and tested marketing techniques to provide the research structure and an easy format to compare growth across different countries and markets over a specific time period. This project uses primary (telephone) and secondary (published and online material) research as the principal methods of data gathering. Interviews for this project primarily focus on the respondent types outlined below:
•Industry participants
•End users
•Key regulatory bodies
•Frost & Sullivan published research services
•Decision Support Databases
•Country Industry Forecasts
•Annual reports published by companies

Key Findings

•In 2014, the global injectable drug delivery market was estimated to be $ x billion, of which, diabetes injectables made up x % at $ x billion.
•The global oral drug delivery market was valued at $ x billion in 2014 with oral diabetes drugs comprising x % ($ x billion).
•Injectable pens form the most attractive drug delivery sector in the diabetes drug market; major drug companies are planning to launch pipeline products between 2015 and 2020 (e.g., U x and IDegLira).
•Oral insulin and other forms of needleless drug delivery systems, such as Omarigliptin (MK-3102), Metformin Fixed Dose Combination (FDC), and Dallresp (roflumilast), are expected to enter the diabetes market by the end of 2019.
•Insulin inhalers such as Afrezza® from MannKind Corporation are expected to launch in Q1 2015. Insulin patches are under development and could become game changers in the diabetes drug delivery market.
•In 2015, four major diabetes drugs will enter the US and European markets, namely, Afrezza® (MannKind’s inhalable drug distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen).
•Depending on the acceptance of inhalable diabetes drug delivery, the global diabetes drug market can expect increased investment in the future. At present, with the exception of one inhalable drug approved by the Food and Drug Administration (FDA), there are no other inhalable products in the diabetes clinical pipeline.

Unmet Needs in the Diabetes Drug Delivery Market

Patients

•Limited drug delivery options available to patients (oral or injectable)
•Drug discontinuity in aged populations due to memory loss and reimbursement costs
•Rise in patient demand for needleless diabetes drug delivery

Providers
•Disease not under control due to poor patient-adherence to medication regimens and lack of proper disease management
•Oral insulin and other alternate forms to be available after 2 to 3 years
•Efficacy of new drug delivery systems still debatable

Payers
•Difference in insurance schemes from region to region
•Variations in price regulations in important markets

Scope and Segmentation

•This study looks at the global diabetes drug delivery market and is segmented as follows:
oInjectable diabetes drug delivery market
oOral diabetes drug delivery market
oTransdermal patches and inhalable diabetes drug delivery market*
oOther diabetes drug deliveries market (implantable devices and artificial pancreas)**
•The study is also segmented by region:
oThe United States
oEurope
oAsia-Pacific

Key Questions This Study Will Answer

Which is the most preferred diabetes drug delivery system?
What are the market trends that will impact existing diabetes drug delivery systems?
What are the key companies to watch in the upcoming years?
What are the new emerging diabetes drug delivery systems?
What are the key drivers and restraints in the diabetes drug delivery market?
Which are the main competitors in each type of diabetes drug delivery market?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Topical Drug Delivery Market by Product Type, Transdermal, Route of Administration, & Facility of Use - Global Forecast to 2021

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global topical drug delivery market is poised to reach USD 125.88 billion by 2021 from USD 92.40 billion in 2016, growing at a CAGR of 6.4% from 2016 to 2021. Major factors driving the growth of this ...

Self Administered Injectable Drug Delivery Systems: Products, Therapeutics, Markets, Players and Forecasts

  • $ 4850
  • Industry report
  • June 2017
  • by Greystone Research Associates

Self Administered Injectable Drug Delivery Systems: Products, Therapeutics, Markets, Players and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing ...

Topical Drug Delivery - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • April 2017
  • by Stratistics MRC

According to Stratistics MRC, the Global Topical Drug Delivery market is estimated at $89.76 billion in 2016 and is expected to reach $134.58 billion by 2022 growing at a CAGR of 7.0% from 2016 to 2022. ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.